Ro Eb News Today

By Adria Calatayud Roche Holding is scheduled to report results for 2023 on Thursday. Here is what you need to know. SALES FORECAST: The Swiss pharmaceutical...

By Andrea Figueras Roche said it obtained positive results for its investigational treatment, inavolisib, as a first-line treatment for people with breast...

By Andrea Figueras Roche said that it has received positive long-term follow-up data and significant overall survival benefit from the Katherine study, which...

By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing...

By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The...

By Adria Calatayud Roche Holding said it received approval from the U.S. Food and Drug Administration for Vabysmo as treatment of macular edema following...

By Adria Calatayud Roche Holding has agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion that will give it...

By Colin Kellaher AbbVie on Friday said a Phase 3 study evaluating the safety and efficacy of its venetoclax cancer drug in combination with dexamethasone...

By Giulia Petroni Roche said the U.K.'s medicines regulator has approved its Tecentriq intravenous cancer therapy. The Swiss pharmaceutical company said...

By Sarah Sloat Swiss pharma company Roche said Friday it has received a positive opinion from the European Union that would extend use of its Evrysdi...